Julien's Primer of Drug Action
Worth Publishers Inc.,U.S. (Verlag)
978-1-319-24894-9 (ISBN)
Julien’s Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations.
The thoroughly updated 14th edition features:
New coverage of opioids of abuse, and drugs used to treat of opioid dependence and opioid overdose
New research on the use of marijuana to treat Alzheimers, PTSD, and Epilepsy
New coverage of pharmacological, physiological, and psychoactive effects of synthetic marijuana including its toxicity
New research on Cannabidiol (CBD) and its therapeutic uses
New research of the efficacy of antipsychotics to treat dementia, Parkinson’s, bipolar, OCD, and PTSD
The use of genetic testing to predict effectiveness of antidepressant treatment
New research on the use of ketamine for the treatment of depression
Claire Advokat received her Ph.D. in physiological psychology from Rutgers University. Her research area is psychopharmacology, specifically drugs used in the treatment of psychiatric and behavioral disorders. She has published over 80 articles, and received funding for her studies from the National Institute of Drug Abuse (NIDA), the Spencer Foundation, the Board of Regents of Louisiana, the State of Louisiana, and the pharmaceutical firm NPS. She received a university teaching award in 2005, served as an ad hoc reviewer for 20 journals, and serves on the editorial board of The Journal of Attention Disorders.
Part 1 Biological Basis of Drug Action1. The Neuron, Synaptic Transmission, and Neurotransmitters.- 2. Pharmacokinetics: How the Body Handles Drugs.- 3. Pharmacodynamics: How Drugs Act.- Part 2 Pharmacology of Drugs of Abuse.- 4. Neurobiology of Addiction.- 5. Ethyl Alcohol and the Inhalants of Abuse.- 6. Stimulants Part .- 1 Caffeine and Nicotine7. Stimulants Part.- 2 Cocaine, Amphetamine, NonAmphetamine Stimulants.- 8. Hallucinogens.- 9. Cannabinoids.- 10. Opioids .- Part 3 Drugs Used to Treat Psychological Disorders.- 11. Antipsychotic Drugs: Major Tranquilizers to Thymic Stabilizers.- 12. Antidepressant Drugs.- 13. Sedative-Hypnotic and Anxiolytic Medications.- 14. Drugs Used to Treat Bipolar Disorder.- Part 4 Special Populations and Integration.- 15. Child and Adolescent Psychopharmacology.- 16. Geriatric Psychopharmacology.- 17. Integration.- Chapter 17 Appendix: Quick .- Reference to Psychotropic Medications.
| Erscheinungsdatum | 08.11.2018 |
|---|---|
| Zusatzinfo | 672 p. |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Geisteswissenschaften ► Psychologie ► Persönlichkeitsstörungen |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
| Schlagworte | Antidepressiva • Bipolar Disorder • Cannabinoid • Cocaine • Drug • Drug research • drugs of abuse • DSM-5 • Kinetics • Nicotin • Pharmacodynamics • Pharmacokinetics • pharmacology • Psychopharmacology • Research |
| ISBN-10 | 1-319-24894-2 / 1319248942 |
| ISBN-13 | 978-1-319-24894-9 / 9781319248949 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
